RET and non-small cell lung carcinoma: In this multicenter retrospective research of RET-fusion-positive NSCLC patients, we described the clinical characteristics and compared the efficacy among the latest treatment regimens including RET-TKI, chemotherapy, ICI-based regimens, and MKI.